+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Protein Kinases"

Mitogen Activated Protein Kinase 14 - Pipeline Review, H2 2019 - Product Thumbnail Image

Mitogen Activated Protein Kinase 14 - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 79 Pages
  • Global
From
Tyrosine Protein Kinase Receptor TYRO3 - Pipeline Review, H2 2019 - Product Thumbnail Image

Tyrosine Protein Kinase Receptor TYRO3 - Pipeline Review, H2 2019

  • Drug Pipelines
  • November 2019
  • 40 Pages
  • Global
From
Angiopoietin 1 Receptor - Pipeline Review, H2 2019 - Product Thumbnail Image

Angiopoietin 1 Receptor - Pipeline Review, H2 2019

  • Drug Pipelines
  • August 2019
  • 141 Pages
  • Global
From
Receptor Tyrosine Protein Kinase ERBB 3 - Pipeline Review, H2 2019 - Product Thumbnail Image

Receptor Tyrosine Protein Kinase ERBB 3 - Pipeline Review, H2 2019

  • Drug Pipelines
  • August 2019
  • 100 Pages
  • Global
From
From
From
From
From
Loading Indicator

Protein Kinases are a type of enzyme that catalyzes the transfer of phosphate groups from high-energy donor molecules to proteins. They are involved in a wide range of cellular processes, including cell growth, differentiation, and metabolism. Protein Kinases are also involved in signal transduction pathways, which are essential for the regulation of cell behavior. Protein Kinases are important drug targets for the treatment of various diseases, including cancer, diabetes, and cardiovascular diseases. The Protein Kinases market is a rapidly growing segment of the enzymes market. It is driven by the increasing prevalence of chronic diseases, the growing demand for targeted therapies, and the development of novel technologies for drug discovery. The market is also driven by the increasing demand for protein kinase inhibitors, which are used to treat various diseases. Some of the major companies in the Protein Kinases market include Merck & Co., Inc., Pfizer Inc., Novartis AG, AstraZeneca plc, and Bristol-Myers Squibb Company. Show Less Read more